RxDoctor Payments Data

John Callahan, MD

Family Medicine · Aurora, NCNPI 1609988393

Payments from drug & device makers

$2,797in general payments, 2019–2025

Across 159 payments — averaging $17.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$346
  • Novo Nordisk$313
  • AstraZeneca$268
  • GSK$263
  • Pfizer$232
  • Amgen$207
  • plus $1K from 21 others

What the payments were for

  • Food & beverage$2,797100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,797 in reported general payments places this provider in the 80th percentile of 3,444 family medicine providers in North Carolina.

See all family medicine providers in North Carolina

Medicare billing

Part B allowed, 2024
$207,261
Medicare patients
559
Services billed
4,865

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban306$240,069
JardianceEmpagliflozin178$136,525
Humira(Cf) PenAdalimumab11$74,626
XareltoRivaroxaban74$73,165
Trelegy ElliptaFluticasone/Umeclidin/Vilanter99$68,597
FarxigaDapagliflozin Propanediol70$61,841
TrulicityDulaglutide22$42,699
JanuviaSitagliptin Phosphate44$39,545
EntrestoSacubitril/Valsartan33$33,429
OzempicSemaglutide22$32,779
LinzessLinaclotide44$27,154
MyrbetriqMirabegron31$26,387
Janumet XrSitagliptin Phos/Metformin Hcl28$19,087
SymbicortBudesonide/Formoterol Fumarate52$18,364
Spiriva HandihalerTiotropium Bromide28$15,147

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis, Premarin$232$243,977319 claims
GSKTrelegy Ellipta, Anoro Ellipta, Breo Ellipta$263$94,932157 claims
AstraZenecaFarxiga, Symbicort$268$80,205122 claims
Johnson & JohnsonXarelto$28$73,16574 claims
MerckJanuvia, Janumet Xr$156$58,63272 claims
Lilly USA, LLCTrulicity, Mounjaro$346$56,63035 claims
NovartisEntresto$109$33,42933 claims
Novo NordiskOzempic$313$32,77922 claims
AbbVieLinzess$106$27,15444 claims
Astellas Pharma US IncMyrbetriq$34$26,38731 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 3,444 family medicine providers in North Carolina.

Other family medicine in Aurora

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →